Topic: Jeffrey Kindler
I attended a fantastic conference on corporate governance last week at the Millstein Center at Yale University in New Haven. The conference (like...
M. Anthony Burns has been a director of Pfizer (NYSE: PFE) since 1988 when the company went through several disastrous M&A events. Since then he's...
While 2009 was the year of the big acquisition, 2010 will likely go down as the year of disappointment and uncertainty in the pharmaceutical...
Drug maker Pfizer Inc. (PFE) will pay its new chief executive, Ian Read, a base salary of $1.7 million plus a bonus for 2011. . . Read's bonus...
File this under eminence grise. For all the chatter about the sudden departure of Pfizer (PFE) CEO Jeff Kindler, a focal point of this boardroom...
Analysts have welcomed the surprise resignation of Pfizer (PFE) CEO Jeffrey Kindler earlier this week. But some remain skeptical that his...
Pfizer's outgoing CEO Jeffrey Kindler will receive $9.6 million cash as part of compensationOutgoing Pfizer CEO Jeffery B. Kindler will receive about $9.6 million in cash, plus stock incentives, as part of his compensation after abruptly leaving the drug ...
Pfizer (PFE) chief executive Jeffrey Kindler retired unexpectedly over the weekend, and the company named head of global biopharma operations, Ian...
Summary Box: Pfizer names Ian Read CEO to replace Jeffrey KindlerTHE ANNOUNCEMENT: Pfizer Inc. named Ian Read CEO in an unexpected move to replace Jeffery Kindler.OVERVIEW: The move comes as the company deals with a declining share price, repeated failures of ...
Pfizer Inc. may be the world's biggest drugmaker, but new CEO Ian Read is taking charge at a trying time for the company, and he will have to deal with a declining share price, repeated failures of potential new products and ...
